KP Tissue Inc's stock has seen a slight decline this week amidst some upcoming corporate events.
This week, KP Tissue Inc (KPT.TO) experienced a minor dip in its stock price, closing at C$12.82 with a 1D change of -0.08%. Over the past week, the stock has decreased by 1.91%, while its year-to-date performance remains strong at +25.44%. Investors are now looking toward upcoming financial announcements and shareholder meetings.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$128.66M
P/E
14.3x
52W high
$13.61
52W low
$8.29
1W change
-1.91%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 0.4% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.88
+0.4% Upside
Current Price
C$12.82
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
17.7%
Annualized
90-Day Vol
16.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$15.33
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$13.61 | C$12.80 โ C$14.46 |
| 60 trading days | C$14.44 | C$13.24 โ C$15.75 |
| 90 trading days | C$15.33 | C$13.79 โ C$17.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: KP Tissue's recent performance reflects broader market trends, but upcoming events may provide further insights into its financial health and strategic direction.
KP Tissue's stock has a market cap of C$128.66 million and is trading within 85% of its 52-week range.
With a P/E ratio of 14.26 and a beta of 0.40, KP Tissue Inc shows a relatively stable investment profile, but its profit margin remains at 0.0%.
Bull case
The company has shown solid performance this year and is set to release its Q2 2026 financial results on July 13, 2026. This report could indicate continued growth for the company.
Bear case
The recent slight decline in stock price and the absence of immediate catalysts may raise concerns for investors about potential short-term volatility.
Recent Price Action
KP Tissue Inc's stock closed at C$12.82, reflecting a minor decline of 0.08% for the day. Over the past week, the stock has fallen by 1.91%, while it has gained 25.44% year-to-date. The latest trading volume was 28,347 shares, significantly above the 20-day average of 15,469 shares, indicating increased trading activity.
Upcoming Corporate Events
KP Tissue has announced several important upcoming events, including the release of its Q2 2026 financial results, which is scheduled for July 13, 2026. This will be a key moment for investors, as it will provide insights into the company's performance amid current market conditions. Additionally, the company held its Annual Meeting of Shareholders on June 8, 2026, where director elections were conducted, and advisory firms recommended support for all resolutions.
Technical Picture
From a technical perspective, KP Tissue is currently trading above its 50-day moving average of C$12.65 (+1.3%) and significantly above its 200-day moving average of C$10.93 (+17.3%). The stock's 52-week range is C$8.29 to C$13.61, indicating it is currently trading at approximately 85% of its 52-week high. With a beta of 0.40, KP Tissue shows lower volatility compared to the broader market.
Advertisement
